Targeting human {gamma}delta} T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/17671215

Cancer Res. 2007 Aug 1 67 15 7450-7

Download in:

View as

General Info

PMID
17671215